ABGX

Abgenix, Inc.
Exchange: Nasdaq
Develops and intends to commercialize antibody therapeutic products for the treatment of a variety of disease conditions, including transplant-related diseases, inflammatory and autoimmune disorders, cardiavascular disease, infectious diseases and cancer.